JANX logo

Janux Therapeutics, Inc. (JANX) Shareholders Equity

Annual Shareholders Equity:

$1.02B+$678.43M(+197.02%)
December 31, 2024

Summary

  • As of today, JANX annual stockholders equity is $1.02 billion, with the most recent change of +$678.43 million (+197.02%) on December 31, 2024.
  • During the last 3 years, JANX annual shareholders equity has risen by +$656.45 million (+179.20%).
  • JANX annual shareholders equity is now at all-time high.

Performance

JANX Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXbalance sheet metrics

Quarterly Shareholders Equity:

$990.52M-$21.95M(-2.17%)
June 30, 2025

Summary

  • As of today, JANX quarterly stockholders equity is $990.52 million, with the most recent change of -$21.95 million (-2.17%) on June 30, 2025.
  • Over the past year, JANX quarterly shareholders equity has increased by +$332.84 million (+50.61%).
  • JANX quarterly shareholders equity is now -3.15% below its all-time high of $1.02 billion, reached on December 31, 2024.

Performance

JANX Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

JANX Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+197.0%+50.6%
3Y3 Years+179.2%+188.1%
5Y5 Years+10000.0%-

JANX Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+218.9%-3.1%+230.8%
5Y5-Yearat high>+9999.0%-3.1%+6866.7%
All-TimeAll-Timeat high>+9999.0%-3.1%+6866.7%

JANX Shareholders Equity History

DateAnnualQuarterly
Jun 2025
-
$990.52M(-2.2%)
Mar 2025
-
$1.01B(-1.0%)
Dec 2024
$1.02B(+197.0%)
$1.02B(+55.9%)
Sep 2024
-
$656.10M(-0.2%)
Jun 2024
-
$657.68M(+0.3%)
Mar 2024
-
$655.76M(+90.4%)
Dec 2023
$344.35M(+7.4%)
$344.35M(-1.3%)
Sep 2023
-
$348.95M(+16.5%)
Jun 2023
-
$299.47M(-3.8%)
Mar 2023
-
$311.26M(-3.0%)
DateAnnualQuarterly
Dec 2022
$320.74M(-12.4%)
$320.74M(-3.2%)
Sep 2022
-
$331.51M(-3.6%)
Jun 2022
-
$343.81M(-3.4%)
Mar 2022
-
$356.08M(-2.8%)
Dec 2021
$366.33M(+5143.7%)
$366.33M(-2.8%)
Sep 2021
-
$376.75M(-2.1%)
Jun 2021
-
$384.80M(+535.2%)
Mar 2021
-
$60.58M(+513.8%)
Dec 2020
$6.99M(+187.9%)
-$14.64M
Dec 2019
-$7.94M
-

FAQ

  • What is Janux Therapeutics, Inc. annual stockholders equity?
  • What is the all-time high annual shareholders equity for Janux Therapeutics, Inc.?
  • What is Janux Therapeutics, Inc. annual shareholders equity year-on-year change?
  • What is Janux Therapeutics, Inc. quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for Janux Therapeutics, Inc.?
  • What is Janux Therapeutics, Inc. quarterly shareholders equity year-on-year change?

What is Janux Therapeutics, Inc. annual stockholders equity?

The current annual shareholders equity of JANX is $1.02B

What is the all-time high annual shareholders equity for Janux Therapeutics, Inc.?

Janux Therapeutics, Inc. all-time high annual stockholders equity is $1.02B

What is Janux Therapeutics, Inc. annual shareholders equity year-on-year change?

Over the past year, JANX annual stockholders equity has changed by +$678.43M (+197.02%)

What is Janux Therapeutics, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of JANX is $990.52M

What is the all-time high quarterly shareholders equity for Janux Therapeutics, Inc.?

Janux Therapeutics, Inc. all-time high quarterly stockholders equity is $1.02B

What is Janux Therapeutics, Inc. quarterly shareholders equity year-on-year change?

Over the past year, JANX quarterly stockholders equity has changed by +$332.84M (+50.61%)
On this page